EXIT-CVD
EXIT-CVD is a five-year European programme exploring earlier detection, personalised monitoring and targeted treatment to interrupt the progression of cardiovascular disease. Two studies focus on under-recognised aspects of women’s cardiovascular health: EMPOWER-BP investigates spontaneous coronary artery dissection (SCAD) and angina/ischaemia with non-obstructive …
BigData@Heart – RATE-AF: Atrial Fibrillation
The RATE-AF trial (RAte control Therapy Evaluation in permanent Atrial Fibrillation) represents a landmark shift in how we manage one of the world’s most common heart rhythm disorders. Funded by the National Institute for Health and Care Research (NIHR) and supported by …
